Adipocytokines: emerging mediators of the immune response and inflammation;Las adipocinas: mediadores emergentes de la respuesta inmune y de la inflamación

Reumatologia Clinica

Volumn 5, Issue SUPPL. 1, 2009, Pages 6-12

  Gómez, Rodolfo ^a   Conde, Javier ^a   Gómez Reino, Juan J ^a,b,c   Lago, Francisca ^a   Gualillo, Oreste ^a  

^a Santiago University Clinical Hospital   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Adipocytokines; Immune system; Inflammation; Osteoarthritis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AUTOANTIBODY; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ARTICLE; AUTOIMMUNE DISEASE; GENE; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY DISEASE; OB GENE; PATHOPHYSIOLOGY; RHEUMATIC DISEASE; WHITE ADIPOSE TISSUE; HUMAN; MEDIATOR; OBESITY; OSTEOARTHRITIS; REVIEW;

EID: 64749092453     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2008.12.003     Document Type: Article

References (38)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
2. Otero M., Lago R., Lago F., Casanueva F.F., Dieguez C., Gómez-Reino J.J., et al. Leptin, from fat to inflammation: Old questions and new insights. FEBS Lett 579 (2005) 295-301
3. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (2005) 911-919 quiz 920
4. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
5. Tilg H., and Moschen A.R. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006) 772-783
6. Otero M., Lago R., Gómez R., Dieguez C., Lago F., Gómez-Reino J., et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45 (2006) 944-950
7. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 393 (2006) 7-20
8. Gualillo O., Eiras S., White D.W., Dieguez C., and Casanueva F.F. Leptin promotes the tyrosine phosphorylation of SHC proteins and SHC association with GRB2. Mol Cell Endocrinol 190 (2002) 83-89
9. Howard J.K., Lord G.M., Matarese G., Vendetti S., Ghatei M.A., Ritter M.A., et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104 (1999) 1051-1059
10. Matarese G., Moschos S., and Mantzoros C.S. Leptin in immunology. J Immunol 174 (2005) 3137-3142
11. Faggioni R., Feingold K.R., and Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 15 (2001) 2565-2571
12. De Rosa V., Procaccini C., Cali G., Pirozzi G., Fontana S., Zappacosta S., et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26 (2007) 241-255
13. Otero M., Lago R., Gómez R., Lago F., Dieguez C., Gómez-Reino J.J., et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65 (2006) 1198-1201
14. Toussirot E., Streit G., and Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 14 (2007) 1095-1100
15. Fraser D.A., Thoen J., Reseland J.E., Forre O., and Kjeldsen-Kragh J. Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18 (1999) 394-401
16. Bernotiene E., Palmer G., and Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res Ther 8 (2006) 217
17. Gualillo O. Further evidence for leptin involvement in cartilage homeostases. Osteoarthritis Cartilage 15 (2007) 857-860
18. Otero M., Gómez Reino J.J., and Gualillo O. Synergistic induction of nitric oxide synthase type II: In vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 48 (2003) 404-409
19. Otero M., Lago R., Lago F., Reino J.J., and Gualillo O. Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: Synergistic effect of leptin with interleukin-1. Arthritis Res Ther 7 (2005) R581-R591
20. Simopoulou T., Malizos K.N., Iliopoulos D., Stefanou N., Papatheodorou L., Ioannou M., et al. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 15 (2007) 872-883
21. Iliopoulos D., Malizos K.N., and Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 66 (2007) 1616-1621
22. Oh D.K., Ciaraldi T., and Henry R.R. Adiponectin in health and disease. Diabetes Obes Metab 9 (2007) 282-289
23. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
24. Matsuzawa Y. Therapy insight: Adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3 (2006) 35-42
25. Schaffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Scholmerich J., et al. Adipocytokines in synovial fluid. JAMA 290 (2003) 1709-1710
26. Sada K.E., Yamasaki Y., Maruyama M., Sugiyama H., Yamamura M., Maeshima Y., et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33 (2006) 1545-1552
27. Ehling A., Schaffler A., Herfarth H., Tarner I.H., Anders S., Distler O., et al. The potential of adiponectin in driving arthritis. J Immunol 176 (2006) 4468-4478
28. Lago R., Gómez R., Otero M., Lago F., Gallego R., Dieguez C., et al. A new player in cartilage homeostasis: Adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 16 (2008) 1101-1109
29. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
30. Harsch I.A., Koebnick C., Wallaschofski H., Schahin S.P., Hahn E.G., Ficker J.H., et al. Resistin levels in patients with obstructive sleep apnoea syndrome--the link to subclinical inflammation?. Med Sci Monit 10 (2004) CR510-CR515
31. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., and Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
32. Lehrke M., Reilly M.P., Millington S.C., Iqbal N., Rader D.J., and Lazar M.A. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1 (2004) e45
33. Bokarewa M., Nagaev I., Dahlberg L., Smith U., and Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 174 (2005) 5789-5795
34. Senolt L., Housa D., Vernerova Z., Jirasek T., Svobodova R., Veigl D., et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66 (2007) 458-463
35. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
36. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Retraction. Science 318 (2007) 565
37. Jia S.H., Li Y., Parodo J., Kapus A., Fan L., Rotstein O.D., et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113 (2004) 1318-1327
38. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178 (2007) 1748-1758